Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Reata Pharmaceuticals Inc. (RETA)

  • Event
  • Aug. 08, 2022, 05:31 UTC
  • 96
  • 0 comments

Reata Pharmaceuticals Inc. - Reata Pharmaceuticals Second Quarter 2022 Financial Results and Update on Development Programs

Comment Full text

ALX Oncology Inc (ALXO)

  • Event
  • Aug. 08, 2022, 00:00 UTC
  • 35
  • 1 comments

(75% Positive) ALX ONCOLOGY HOLDINGS INC (ALXO) Reports 47% Loss Reduction for 2022-06-30

Comment Full text

Reata Pharmaceuticals Inc (was by Biogen Inc. (Nasdaq: BIIB) on 26/09/2023) (RETA)

  • Event
  • Aug. 08, 2022, 00:00 UTC
  • 38
  • 1 comments

(51% Neutral) Reata Pharmaceuticals, Inc. (RETA) Reports Net Loss for 2022-06-30

Comment Full text

Karuna Therapeutics (was acquised by Bristol Myers Squibb (NYSE: BMY) on 18/03/2024) (KRTX)

  • Event
  • Aug. 08, 2022, 00:00 UTC
  • 27
  • 1 comments

(75% Positive) Karuna Therapeutics, Inc. (KRTX) Reports 47% Loss Reduction for 2022-06-30

Comment Full text

Tonix Pharmaceuticals Holding Corp (TNXP)

  • Event
  • Aug. 05, 2022, 21:02 UTC
  • 21
  • 1 comments

(99% Neutral) TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Announces Executive Changes

Comment Full text

Avadel Pharmaceuticals (AVDL)

  • Event
  • Aug. 05, 2022, 20:58 UTC
  • 21
  • 1 comments

(99% Neutral) AVADEL PHARMACEUTICALS PLC (AVDL) Announces Regulatory Update

Comment Full text

Brooklyn ImmunoTherapeutics Inc (the company was transformed Eterna Therapeutics (ERNA)) (BTX)

  • Event
  • Aug. 05, 2022, 20:32 UTC
  • 25
  • 1 comments

(99% Neutral) Brooklyn ImmunoTherapeutics, Inc. (BTX) Announces Executive Changes

Comment Full text

Arvinas Inc (ARVN)

  • Event
  • Aug. 05, 2022, 20:12 UTC
  • 23
  • 1 comments

(90% Positive) Arvinas, Inc. (ARVN) Provides Update on availability for bavdegalutamide

Comment Full text

Arcutis Biotherapeutics (ARQT)

  • Event
  • Aug. 05, 2022, 20:02 UTC
  • 21
  • 1 comments

(99% Neutral) ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Announces Business Combination

Comment Full text

Legend Biotech (LEGN)

  • Event
  • Aug. 05, 2022, 12:30 UTC
  • 19
  • 1 comments

(10% Negative) Legend Biotech (LEGN) Announces Clinical Development Update (Form 6-K)

Comment Full text
  • Previous
  • 125
  • 126
  • 127
  • 128
  • 129
  • Next

Search

News categories

  • Technical Exchange News(10870)
  • Event(2243)
  • SEC News(189146)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124506)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin